On 2026-05-11, Aktis Oncology, Inc. (AKTS) announced earnings per share of $-0.38 for the fiscal quarter ending 2026-03-31, missing the average analyst estimate of $-0.31.

The next expected annoucement date for quarterly earnings is 2026-08-10, with an average estimated earnings per share of $-0.40 for the fiscal quarter ending 2026-06-30.

Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.